This is in line with previous reports of an IL-8 mediated resistance to anti-VEGF therapy in renal cell carcinoma where the tumors were re-sensitized to anti-VEGF therapy by the addition of an anti-IL-8 antibody (50). Here, VEGFA is linked to hereditary clear cell renal cell carcinoma.